Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Changes in keratin affect skin health and can lead to skin disorders like blistering diseases and psoriasis.

Prevelex, a polyampholyte, can create a cell-repellent coating on microdevices, which can be useful in biomedical applications like hair follicle regeneration.

A man developed severe skin reactions after using a treatment for hair loss.

Vitiligo and alopecia areata may have similar causes despite their differences.

Splenic eumelanin in C57BL/6 mice is different from hair eumelanin.

A rare skin condition causes red, dark, bumpy facial lesions.

A 93-year-old woman developed a rare scalp condition after therapy, which improved with steroids, not antibiotics.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Lablab purpureus peptides may effectively kill cancer cells with fewer side effects.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Accurate diagnosis of RDEB-mitis in older adults is crucial for proper management without immunosuppressants.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Recognizing keratosis pilaris in all skin tones helps diagnose related skin issues and reduce distress.

Palmitoyl tetrapeptide-20 may help reduce hair greying and increase melanin production.

Langerhans' cells are not involved in hair depigmentation in these mice.

Mouse profilaggrin helps in skin cell differentiation and may be involved in calcium signaling.

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.